Moderna Inc 's ability to collect its outstanding accounts receivable from its corporate clients, has improved in the second quarter 2026 to a ratio of 6.76, above the company average. This is a clear sign of healthy business climate in the Biotechnology & Pharmaceuticals industry and improving liquidity at their respective customers, during the second quarter 2026. Average receivable collection period, for the Moderna Inc in Jun 30 2026 quarter, has decreased to 54 days, compared to 55 days, in the Mar 31 2026 quarter.

If we take a look into Healthcare sector 244 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Jun 30 2026 from 1818 to 1924.

What is Receivable Turnover Ratio?
What is Moderna Inc Selling?

What is Receivable Turnover Ratio?

Select the Comparisons :

None ▼

Select the Ratio:

Accounts Receivables Turnover▼

None ▼

Accounts Receivables Turnover▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

MRNA Receivables Turnover Ratio	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Receivable Change	-52.78 %	-8.97 %	-48.6 %	-33.12 %	-77.91 %
Y / Y Revenue Change	2.11 %	260.19 %	-29.81 %	-45.44 %	-41.08 %
Receivable Turnover Ratio (TTM)	6.76	6.66	5.79	5.88	6.05
MRNA's Total Ranking	# 1924	# 1818	# 2133	# 2047	# 1995
Accounts Receivable average collection period days	54	55	63	62	60
Seq. Receivable Change	-76.06 %	-61.41 %	-82.41 %	2805.56 %	-53.85 %
Seq. Revenue Change	-62.72 %	-42.63 %	-33.27 %	615.49 %	31.48 %

Receivable Turnover Company Ranking
Within:	No.
Biotechnology & Pharmaceuticals Industry	# 24
Healthcare Sector	# 245
Overall Market	# 1924

Receivable Turnover Ratio Statistics
High	Average	Low
7.94	5.67	0.64
(Sep 30 2023)		(Sep 30 2019)

MRNA Company Profile • Back to MRNA Efficiency Comparisons • Compare MRNA Receivables Turnover Ratio to its Competitors

Financial Statements
Moderna Inc 's Accounts Receivable	$ 17 Millions	Visit MRNA's Balance sheet
Moderna Inc 's Sales TTM	$ 2,228 Millions	Visit MRNA's Income Statement
Sources of MRNA's Revenues		Visit MRNA's Sales by Geography

Other Accounts Receivable Turnover Ratios
Biotechnology & Pharmaceuticals Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
MRNA's Receivable Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
MRNA's Growth Rates	MRNA's Roa	MRNA's Inventory Turnover Ratio	MRNA's Dividend Comparisons
MRNA's Profitability Ratios	MRNA's Roi	MRNA's Asset Turnover Ratio	MRNA's Dividend Growth
MRNA's Valuation Ratios	MRNA's Roe	MRNA's Financial Strength Ratios	MRNA's Dividend Payout Ratio

Companies with similar Receivables Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector	Receivable Turnover Ratio	Revenues for 12 Months ending Jun 30 2026	Receivable at quarter ending Jun 30 2026
Immunocore Holdings Plc	195.08	$ 430.775 Millions	$ 2.208 Millions
Agape Atp Corporation	190.27	$ 1.152 Millions	$ 0.006 Millions
Hcw Biologics Inc	175.24	$ 6.843 Millions	$ 0.039 Millions
Warby Parker Inc	161.02	$ 912.542 Millions	$ 5.667 Millions
Assembly Biosciences Inc	94.77	$ 74.845 Millions	$ 0.790 Millions
Arcus Biosciences Inc	93.60	$ 117.000 Millions	$ 1.250 Millions
Earth Science Tech Inc	88.94	$ 34.647 Millions	$ 0.390 Millions
Sbc Medical Group Holdings Incorporated	86.85	$ 173.713 Millions	$ 2.000 Millions
Lenz Therapeutics Inc	77.11	$ 21.475 Millions	$ 0.279 Millions
Airsculpt Technologies Inc	64.88	$ 150.724 Millions	$ 2.323 Millions
Arrowhead Pharmaceuticals Inc	60.05	$ 669.495 Millions	$ 11.149 Millions
Fortrea Holdings Inc	56.65	$ 2,676.500 Millions	$ 47.250 Millions
Humacyte Inc	52.69	$ 30.074 Millions	$ 0.571 Millions
Brookdale Senior Living Inc	47.66	$ 3,050.697 Millions	$ 64.009 Millions
National Vision Holdings Inc	44.61	$ 2,033.426 Millions	$ 45.586 Millions
Meiragtx Holdings Plc	40.72	$ 397.501 Millions	$ 9.762 Millions
Nature s Sunshine Products inc	39.24	$ 491.790 Millions	$ 12.532 Millions
Bioadaptives Inc	35.76	$ 0.026 Millions	$ 0.001 Millions
Lifevantage Corp	35.05	$ 180.947 Millions	$ 5.162 Millions
Electrocore Inc	34.09	$ 36.527 Millions	$ 1.072 Millions
Innovative Eyewear Inc	31.49	$ 3.412 Millions	$ 0.108 Millions
Mangoceuticals Inc	31.43	$ 0.315 Millions	$ 0.010 Millions
Cv Sciences Inc	31.22	$ 12.066 Millions	$ 0.387 Millions
Jaguar Health Inc	30.23	$ 27.815 Millions	$ 0.920 Millions
Invo Fertility Inc	30.20	$ 7.531 Millions	$ 0.249 Millions

Date modified: 2026-08-31T06:04:04+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.